Daniel C. Devor

4.3k total citations
70 papers, 3.6k citations indexed

About

Daniel C. Devor is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Daniel C. Devor has authored 70 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 20 papers in Cardiology and Cardiovascular Medicine and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Daniel C. Devor's work include Ion channel regulation and function (38 papers), Cardiac electrophysiology and arrhythmias (19 papers) and Cystic Fibrosis Research Advances (15 papers). Daniel C. Devor is often cited by papers focused on Ion channel regulation and function (38 papers), Cardiac electrophysiology and arrhythmias (19 papers) and Cystic Fibrosis Research Advances (15 papers). Daniel C. Devor collaborates with scholars based in United States, New Zealand and United Kingdom. Daniel C. Devor's co-authors include Robert J. Bridges, Raymond A. Frizzell, Sham S. Kakar, Jeffrey C. Sellers, Jimmy D. Neill, Lois C. Musgrove, Joseph M. Pilewski, Aaron C. Gerlach, Colin A. Syme and Ashvani K. Singh and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Daniel C. Devor

68 papers receiving 3.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Daniel C. Devor 2.2k 996 735 609 492 70 3.6k
T. Voyno-Yasenetskaya 2.7k 1.2× 331 0.3× 286 0.4× 751 1.2× 482 1.0× 65 4.4k
Finn Olav Levy 2.5k 1.1× 179 0.2× 794 1.1× 1.1k 1.8× 382 0.8× 131 4.1k
Richard Z. Lin 2.3k 1.0× 328 0.3× 726 1.0× 547 0.9× 384 0.8× 81 3.9k
Françoise Cluzeaud 3.0k 1.3× 578 0.6× 266 0.4× 732 1.2× 566 1.2× 71 4.5k
Patrick J. Schultheis 2.7k 1.2× 634 0.6× 212 0.3× 213 0.3× 403 0.8× 43 3.5k
Franz Theuring 995 0.4× 301 0.3× 341 0.5× 386 0.6× 604 1.2× 95 2.6k
Jens Schlossmann 2.3k 1.0× 186 0.2× 783 1.1× 445 0.7× 1.4k 2.8× 82 3.6k
Peter Vangheluwe 1.9k 0.9× 179 0.2× 555 0.8× 381 0.6× 531 1.1× 86 3.2k
S.-L. Catherine Jin 3.0k 1.3× 217 0.2× 519 0.7× 332 0.5× 648 1.3× 24 4.0k
Kiyoshi Furuichi 1.9k 0.9× 116 0.1× 138 0.2× 468 0.8× 518 1.1× 52 3.5k

Countries citing papers authored by Daniel C. Devor

Since Specialization
Citations

This map shows the geographic impact of Daniel C. Devor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Devor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Devor more than expected).

Fields of papers citing papers by Daniel C. Devor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel C. Devor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Devor. The network helps show where Daniel C. Devor may publish in the future.

Co-authorship network of co-authors of Daniel C. Devor

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel C. Devor. A scholar is included among the top collaborators of Daniel C. Devor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel C. Devor. Daniel C. Devor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolski‐Andreaco, Aaron, Corina Balut, John Sembrat, et al.. (2025). VX-445 (elexacaftor) inhibits chloride secretion across human bronchial epithelial cells by directly blocking KCa3.1 channels. PNAS Nexus. 4(7). pgaf211–pgaf211. 1 indexed citations
2.
Kolski‐Andreaco, Aaron, Scott Hahn, John Sembrat, et al.. (2025). (R)-vanzacaftor potentiates BKCa channels in the absence of CFTR correction or potentiation. American Journal of Physiology-Cell Physiology. 329(4). C1130–C1138.
3.
Kolski‐Andreaco, Aaron, Michael M. Myerburg, John Sembrat, et al.. (2024). Potentiation of BKCa channels by cystic fibrosis transmembrane conductance regulator correctors VX-445 and VX-121. Journal of Clinical Investigation. 134(16). 5 indexed citations
4.
Kolski‐Andreaco, Aaron, Robert J. Bridges, & Daniel C. Devor. (2023). 154 Inhibition of the intermediate (KCa3.1) and small (KCa2.3 and KCa2.2) conductance, Ca2+-activated K+ channels by CFTR correctors. Journal of Cystic Fibrosis. 22. S82–S82. 1 indexed citations
5.
McDonald, Fiona J., et al.. (2022). Role of SNARE Proteins in the Insertion of KCa3.1 in the Plasma Membrane of a Polarized Epithelium. Frontiers in Physiology. 13. 905834–905834.
6.
Bertuccio, Claudia A., Tony T. Wang, Kirk L. Hamilton, et al.. (2018). Plasma membrane insertion of KCa2.3 (SK3) is dependent upon the SNARE proteins, syntaxin-4 and SNAP23. PLoS ONE. 13(5). e0196717–e0196717. 7 indexed citations
7.
Lee, Bob S. L., Daniel C. Devor, & Kirk L. Hamilton. (2017). Modulation of Retrograde Trafficking of KCa3.1 in a Polarized Epithelium. Frontiers in Physiology. 8. 489–489. 4 indexed citations
8.
Bertuccio, Claudia A., Bob S. L. Lee, Guangyu Wu, et al.. (2014). Anterograde Trafficking of KCa3.1 in Polarized Epithelia Is Rab1- and Rab8-Dependent and Recycling Endosome-Independent. PLoS ONE. 9(3). e92013–e92013. 18 indexed citations
9.
Silverman, Gary A., et al.. (2013). A Small Conductance Calcium-Activated K+ Channel in C. elegans, KCNL-2, Plays a Role in the Regulation of the Rate of Egg-Laying. PLoS ONE. 8(9). e75869–e75869. 7 indexed citations
10.
Gao, Yajuan, Claudia A. Bertuccio, Corina Balut, Simon C. Watkins, & Daniel C. Devor. (2012). Dynamin- and Rab5-Dependent Endocytosis of a Ca2+-Activated K+ Channel, KCa2.3. PLoS ONE. 7(8). e44150–e44150. 12 indexed citations
11.
Balut, Corina, Kirk L. Hamilton, & Daniel C. Devor. (2012). Trafficking of Intermediate (KCa3.1) and Small (KCa2.x) Conductance, Ca2+‐Activated K+ Channels: a Novel Target for Medicinal Chemistry Efforts?. ChemMedChem. 7(10). 1741–1755. 35 indexed citations
12.
Balut, Corina, Yajuan Gao, & Daniel C. Devor. (2009). Role of ESCRT Proteins in Controlling the Lysosomal Degradation of KCa3.1 in HEK and Endothelial Cells. Biophysical Journal. 96(3). 472a–472a. 1 indexed citations
13.
Gao, Yajuan, et al.. (2008). Role of S3 and S4 Transmembrane Domain Charged Amino Acids in Channel Biogenesis and Gating of KCa2.3 and KCa3.1. Journal of Biological Chemistry. 283(14). 9049–9059. 31 indexed citations
14.
Baty, Catherine J., et al.. (2007). An NH2-Terminal Multi-Basic RKR Motif Is Required for the ATP-Dependent Regulation of hIK1. Channels. 1(2). 80–91. 20 indexed citations
15.
Syme, Colin A., Kirk L. Hamilton, Aaron C. Gerlach, et al.. (2003). Trafficking of the Ca2+-activated K+Channel, hIK1, Is Dependent upon a C-terminal Leucine Zipper. Journal of Biological Chemistry. 278(10). 8476–8486. 48 indexed citations
16.
Singh, Sangeeta, Colin A. Syme, Ashvani K. Singh, Daniel C. Devor, & Robert J. Bridges. (2001). Benzimidazolone Activators of Chloride Secretion: Potential Therapeutics for Cystic Fibrosis and Chronic Obstructive Pulmonary Disease. Journal of Pharmacology and Experimental Therapeutics. 296(2). 600–611. 132 indexed citations
17.
Kakar, Sham S., et al.. (1994). Rat gonadotropin-releasing hormone ( GnRH) receptor: tissue expression and hormonal regulation of its mRNA. Molecular and Cellular Endocrinology. 101(1-2). 151–157. 70 indexed citations
18.
Strong, Theresa V., Daniel J. Wilkinson, Daniel C. Devor, et al.. (1993). Expression of an abundant alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMP-activated chloride conductance. Human Molecular Genetics. 2(3). 225–230. 76 indexed citations
19.
Kakar, Sham S., Jeffrey C. Sellers, Daniel C. Devor, Lois C. Musgrove, & Jimmy D. Neill. (1992). Angiotensin II type-1 receptor subtype cDNAs: Differential tissue expression and hormonal regulation. Biochemical and Biophysical Research Communications. 183(3). 1090–1096. 273 indexed citations
20.
Kakar, Sham S., Lois C. Musgrove, Daniel C. Devor, Jeffrey C. Sellers, & Jimmy D. Neill. (1992). Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. Biochemical and Biophysical Research Communications. 189(1). 289–295. 300 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026